We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03108131
Brief Title: Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors

First Submitted : March 31, 2017
First Submitted that Met QC Criteria : April 5, 2017
First Posted : April 11, 2017

Last Update Submitted that Met QC Criteria : September 22, 2022
Last Update Posted : September 26, 2022